Caplight Directory>Investors>Crista Galli Ventures>Cristagalli


Crista Galli Ventures

Crista Galli Ventures

London, Englandcristagalli.com

Overview

Crista Galli Ventures is an early-stage venture capital firm founded in 2019 with offices in London and Copenhagen. It is a doctor-led, evergreen fund that invests in pan-European healthtech companies at the Pre-Seed, Seed, and Series A stages. The firm's investment focus is on deep tech, digital health, and personalised medicine, while avoiding biotechnology, drug discovery, and non-software enabled devices. Crista Galli Ventures also operates Crista Galli LABS, a separate investment arm for pre-seed startups, with a commitment to backing founders from under-represented backgrounds.

Portfolio Companies

23

Investments

CompanyDateStageLead
GleamerJun 2025VC RoundCo-investor
Vitrue HealthFeb 2024Series ACo-investor
Parallel HealthSep 2023Pre SeedCo-investor
JudeSep 2023SeedCo-investor
Collective Minds RadiologyAug 2023Series BCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.